These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 30765734)
1. The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis. Neumann K; Ostmann A; Breda PC; Ochel A; Tacke F; Paust HJ; Panzer U; Tiegs G Sci Rep; 2019 Feb; 9(1):2038. PubMed ID: 30765734 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis. Diefenhardt P; Braumann M; Schömig T; Trinsch B; Sierra Gonzalez C; Becker-Gotot J; Völker LA; Ester L; Mandel AM; Hawiger D; Abdallah AT; Schermer B; Göbel H; Brinkkötter P; Kurts C; Benzing T; Brähler S J Am Soc Nephrol; 2023 Aug; 34(8):1366-1380. PubMed ID: 37367205 [TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4 de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T Front Immunol; 2020; 11():574491. PubMed ID: 33193363 [TBL] [Abstract][Full Text] [Related]
5. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function. Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016 [TBL] [Abstract][Full Text] [Related]
6. Human CD8 Machicote A; Belén S; Baz P; Billordo LA; Fainboim L Front Immunol; 2018; 9():2788. PubMed ID: 30555473 [TBL] [Abstract][Full Text] [Related]
7. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. Turner JE; Paust HJ; Steinmetz OM; Peters A; Riedel JH; Erhardt A; Wegscheid C; Velden J; Fehr S; Mittrücker HW; Tiegs G; Stahl RA; Panzer U J Am Soc Nephrol; 2010 Jun; 21(6):974-85. PubMed ID: 20299360 [TBL] [Abstract][Full Text] [Related]
8. T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN. Nosko A; Kluger MA; Diefenhardt P; Melderis S; Wegscheid C; Tiegs G; Stahl RA; Panzer U; Steinmetz OM J Am Soc Nephrol; 2017 Jan; 28(1):185-196. PubMed ID: 27297951 [TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Paust HJ; Ostmann A; Erhardt A; Turner JE; Velden J; Mittrücker HW; Sparwasser T; Panzer U; Tiegs G Kidney Int; 2011 Jul; 80(2):154-64. PubMed ID: 21525855 [TBL] [Abstract][Full Text] [Related]
10. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977 [TBL] [Abstract][Full Text] [Related]
11. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822 [TBL] [Abstract][Full Text] [Related]
12. Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy. Zhulai G; Oleinik E Scand J Immunol; 2022 Mar; 95(3):e13129. PubMed ID: 34936125 [TBL] [Abstract][Full Text] [Related]
14. Human Endothelial Cells Modulate CD4 Lim WC; Olding M; Healy E; Millar TM Front Immunol; 2018; 9():565. PubMed ID: 29628925 [TBL] [Abstract][Full Text] [Related]
15. Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs. Lee DJ; Taylor AW J Leukoc Biol; 2015 Jun; 97(6):1101-9. PubMed ID: 25877928 [TBL] [Abstract][Full Text] [Related]
16. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides. Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Chen D; Tang P; Liu L; Wang F; Xing H; Sun L; Jiang Z Cell Cycle; 2018; 17(7):858-867. PubMed ID: 29493401 [TBL] [Abstract][Full Text] [Related]
18. Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice. Lomas-Neira J; Monaghan SF; Huang X; Fallon EA; Chung CS; Ayala A Front Immunol; 2018; 9():3030. PubMed ID: 30619369 [TBL] [Abstract][Full Text] [Related]
19. Stat3 programs Th17-specific regulatory T cells to control GN. Kluger MA; Luig M; Wegscheid C; Goerke B; Paust HJ; Brix SR; Yan I; Mittrücker HW; Hagl B; Renner ED; Tiegs G; Wiech T; Stahl RA; Panzer U; Steinmetz OM J Am Soc Nephrol; 2014 Jun; 25(6):1291-302. PubMed ID: 24511136 [TBL] [Abstract][Full Text] [Related]
20. PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia. Peligero C; Argilaguet J; Güerri-Fernandez R; Torres B; Ligero C; Colomer P; Plana M; Knobel H; García F; Meyerhans A PLoS Pathog; 2015 Dec; 11(12):e1005270. PubMed ID: 26633181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]